Latest news
Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenue - The Economic TimesThe Economic Times · Sun, 09 Aug 2026 05:42:46 GMTGland Pharma signs CDMO deal for USD 90-100 million annual revenue - scanx.tradescanx.trade · Sun, 09 Aug 2026 04:42:44 GMTTranscenta sells CDMO assets to WuXi Bio to focus on drug pipeline - AllSciAllSci · Fri, 07 Aug 2026 13:23:56 GMTFUJIY Q1 Earnings Fall Y/Y on Bio CDMO Costs, Revenues Rise - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 12:46:00 GMT3 CDMO Stocks with Expanding Margins Amid the Global Pharma Outsourcing Boom - EquitymasterEquitymaster · Fri, 07 Aug 2026 11:40:58 GMTGland Pharma and Neuland Laboratories sign long-term CDMO partnership for sterile APIs - DealroomDealroom · Fri, 07 Aug 2026 07:29:45 GMTHK Market Movers | Transcenta Holding-B (06628) Rises Over 11% Before Midday Amid Planned Sale of CDMO Assets for RMB 190 Million - MoomooMoomoo · Fri, 07 Aug 2026 03:27:14 GMTTranscenta Holding Says Unit To Sell CDMO Assets For RMB190.0 Million - TradingViewTradingView · Fri, 07 Aug 2026 01:45:00 GMT